For research use only. Not for therapeutic Use.
Warfarin is an anti-<wbr></wbr>coagulant used to prevent heart attacks, strokes, and the formation of blood clots. It interferes with the use of vitamin K in the required carboxylation of several vitamin K-<wbr></wbr>dependent proteins in the clotting cascade, preventing the initiation of clotting. (+)-<wbr></wbr>Warfarin differs from (−)-<wbr></wbr>warfarin by being five times less potent as a vitamin K antagonist. However the two isomers are metabolized <em>in vivo</em> by different pathways and (+)-<wbr></wbr>warfarin has a longer terminal elimination half-<wbr></wbr>life (35-<wbr></wbr>58 hours) than (−)-<wbr></wbr>warfarin (24-<wbr></wbr>33 hours).
Catalog Number | R013558 |
CAS Number | 5543-58-8 |
Synonyms | 4-Hydroxy-3-[(1R)-3-oxo-1-phenylbutyl]-2H-1-benzopyran-2-one; R-(+)- ?3-(α-Acetonylbenzyl)-4-hydroxycoumarin; (+)-Warfarin; (R)-Warfarin; Dextrowarfarin; |
Molecular Formula | C19H16O4 |
Purity | ≥95% |
Storage | -20°C |
IUPAC Name | 4-hydroxy-3-[(1R)-3-oxo-1-phenylbutyl]chromen-2-one |
InChI | InChI=1S/C19H16O4/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22/h2-10,15,21H,11H2,1H3/t15-/m1/s1 |
InChIKey | PJVWKTKQMONHTI-OAHLLOKOSA-N |
SMILES | CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O |